[Tumor promotion by inhibitors of protein phosphatase 1 and 2A].
Suganuma
M
M
Saitama Cancer Center Research Institute, Japan.
Fujiki
H
H
D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology / Q000633:toxicity; D008387:Marine Toxins; D052998:Microcystins; D009374:Neoplasms, Experimental / Q000139:chemically induced; D019319:Okadaic Acid / Q000494:pharmacology / Q000633:toxicity; D010080:Oxazoles / Q000494:pharmacology / Q000633:toxicity; D010456:Peptides, Cyclic / Q000494:pharmacology / Q000633:toxicity; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors*; D054645:Protein Phosphatase 1; D011714:Pyrans; D013141:Spiro Compounds
D000935:Antifungal Agents; D008387:Marine Toxins; D052998:Microcystins; D010080:Oxazoles; D010456:Peptides, Cyclic; D011714:Pyrans; D013141:Spiro Compounds; C053079:tautomycin; D019319:Okadaic Acid; C078588:microcystin; C059041:calyculin A; D010749:Phosphoprotein Phosphatases; D054645:Protein Phosphatase 1